List view / Grid view
10 December 2015 | By Victoria White
Teams at The University of Manchester and The Institute of Cancer Research, London, have described detailed development of oxygen-enhanced magnetic resonance imaging (MRI) technology to map areas of oxygen deprivation within tumours.
10 December 2015 | By Victoria White
According to business intelligence provider GBI Research, the global immunology treatment market is set to expand from $61.5 billion in 2015 to reach $74.2 billion in 2022...
10 December 2015 | By PSL
Powder Systems Limited (PSL), an international award-winning manufacturer of filtration, drying and high containment isolators for the pharmaceutical and biopharmaceutical industries, recently delivered several advanced process installations in Singapore...
10 December 2015 | By Victoria White
The companies are to evaluate Lilly’s abemaciclib (LY2835219) and Merck’s Keytruda (pembrolizumab) in a Phase I study across multiple tumour types...
10 December 2015 | By Victoria White
According to PaizaBio, a company focused on helping Western-based pharmaceutical companies manufacture drugs in China for the Chinese market, the new policies will impact both Chinese and Western pharmaceutical companies...
10 December 2015 | By Victoria White
Faster-acting insulin aspar is an investigational mealtime insulin developed by Novo Nordisk for the control of blood sugar levels in adults with type 1 and type 2 diabetes...
9 December 2015 | By Victoria White
Vonvendi [von Willebrand factor (Recombinant)] is the first and only recombinant treatment for adults living with von Willebrand Disease (VWD)...
9 December 2015 | By Victoria White
Kanuma (sebelipase alfa) has been approved for the treatment of patients with a diagnosis of lysosomal acid lipase deficiency (LAL-D)...
9 December 2015 | By Victoria White
The treatment market for acute myeloid leukaemia (AML) will rapidly expand in value from $342.7 million in 2014 to reach $932.6 million by 2024, says research and consulting firm GlobalData.
9 December 2015 | By Victoria White
In a small trial, where healthy adult volunteers were given a course of ebselen, the results showed that ebselen had similar effects on the brain to lithium...
9 December 2015 | By Victoria White
The ibuprofen patch delivers the drug directly through skin to exactly where it is needed at a consistent dose rate...
8 December 2015 | By Victoria White
The analysis found a 67% reduction in the risk of disease progression or death in patients receiving idelalisib plus bendamustine and rituximab (BR) compared to placebo plus BR...
8 December 2015 | By Victoria White
Debio1143 is an oral, small molecule inhibitor of IAPs with a dual pro-apoptotic and immunomodulatory mode of action developed as a potent chemo/radiosensitiser in ovarian cancer...
8 December 2015 | By
MGB-BP-3 is an antibiotic that is being developed for the potential treatment of Clostridium difficile infections...
8 December 2015 | By Victoria White
New data, presented at AES 2015, show that Eisai's Fycompa (perampanel) treatment reduces primary and secondary generalised tonic clonic seizures and is well tolerated versus placebo...
